The MoU has been signed under the Bharatmala Pariyojana across the country to centralize freight consolidation and reduce logistics costs from 14% to less than 10% of GDP.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS